Diabetes research information and news.
Previously Published on Medical News Today – New research uses stem cells and a tiny device, the implant reverses type 1 diabetes in mice. Insulin-secreting beta cells can reverse type 1 diabetes in mice. Introducing these cells without triggering the immune system has been a critical challenge. Researchers have developed an apparently safe, functional device for delivery…
Previously Published on Medscape.com – A US Food and Drug Administration (FDA) advisory panel has voted narrowly to recommend approval of the monoclonal antibody teplizumab (Tzield,Provention Bio) for the delay of type 1 diabetes in at-risk individuals. (FDA Endorses Teplizumab) The 10-7 vote of the FDA’s Endocrinologic and Metabolic Drugs advisory committee on May 27 reflected a…
Previously Published on Eurekalert.org – A clinical study led by Linköping University and financed by pharmaceuticals company Diamyd Medical has investigated whether immunotherapy against type 1 diabetes can preserve the body’s own production of insulin. The results suggest that injection of a protein, GAD, into lymph nodes (diabetes vaccine) can be effective in a subgroup of individuals….
Previously Published on Diabetes Daily ViaCyte Interview By Christine Fallabel – I recently had the opportunity to sit down with Manasi Sinha Jaiman, M.D., M.P.H., Vice President of Clinical Development, and Mark Daniels, Senior Director of Clinical Development, of ViaCyte, “a regenerative medicine company focused on delivering novel stem cell-derived cell replacement therapies as a functional cure for all…
Previously Published on BioSpace.com – Prescription drug could eliminate insulin dependence in people with type 1 diabetes. Newly diagnosed patients sought for clinical trial. 300,000 Canadians are living with type 1 diabetes (T1D). There is no known cause or cure. The number of new cases is increasing by approximately 5% every year in Canada. With an annual…
Previously Published on WebMD – MONDAY, March 8, 2021 (HealthDay News) — Just two weeks of treatment with an experimental drug can delay the onset of type 1 diabetes by several years, researchers report. The drug, called teplizumab, is already under review by the U.S. Food and Drug Administration based on earlier evidence of its effectiveness….
Previously Published on MedicalNewsToday – Diabetes keeps the body from being able to regulate levels of glucose in the blood. In the long term, this can lead to a wide range of life-changing complications, including vision loss, kidney damage, stroke, and heart disease. Therefore, transforming alpha cells into beta cells makes sense. In the United…
A Canadian study has concluded a novel dual-hormone artificial pancreas system improves glucose control in patients with type 1 diabetes. Researchers from McGill University’s Faculty of Medicine compared the dual-hormone system with a rapid insulin-alone artificial pancreas. According to the findings the D-HAP increased the blood glucose time in range from 74% to 84%. The…
Diabetes Cured in Mice Using New Human Stem Cell Therapy Researchers from Washington University School of Medicine have cured mice of diabetes using a new human stem cell therapy. The technique converts human stem cells into insulin-producing cells. When the insulin secreting cells were infused into mice with severe diabetes, within two weeks their blood glucose…